DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Optimizing the Management of Flares in Patients With Rheumatoid Arthritis (RA)

Information source: Mayo Clinic
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Rheumatoid Arthritis

Intervention: FLARE Intervention Group (Other)

Phase: N/A

Status: Recruiting

Sponsored by: Mayo Clinic

Official(s) and/or principal investigator(s):
Eric L Matteson, M.D., Principal Investigator, Affiliation: Mayo Clinic

Overall contact:
Zoran Kvrgic, CCRP, Phone: 507-538-3887, Email: Kvrgic.zoran@mayo.edu


The purpose of this study is to determine how best to monitor for flares in patients with rheumatoid arthritis (RA).

Clinical Details

Official title: Optimization of the Flare Management in Rheumatoid Arthritis (RA) by Implementing Patient-driven Systematic Changes to the RA Ambulatory Care Stream

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Primary outcome:

Flare Occurrence

Flare-to-visit Time

Secondary outcome: Participant Satisfaction

Detailed description: This project is aimed at developing an improved multilevel care process model for the management of rheumatoid arthritis (RA) disease activity by implementing systematic self-monitoring of flare experiences by RA patients, combined with continuous patient-tailored adjustments of treatment modalities by a coordinated team of rheumatology health care providers (RHCPs).


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria

- Patient must be ≥ 18 years of age.

- Patient must have been seen by a rheumatology health care provider at least two times

within the last 18 months at Mayo Clinic Rochester.

- Patient must have rheumatoid arthritis (RA) according to the 2010 ACR/EULAR

classification criteria.

- Patient must have the ability to understand and the willingness to sign a written

informed consent document.

- Patient must be willing to return to Mayo Clinic Rochester for follow-up appointments

and fill out questionnaires as outlined in the study.

Locations and Contacts

Zoran Kvrgic, CCRP, Phone: 507-538-3887, Email: Kvrgic.zoran@mayo.edu

Mayo Clinic in Rochester, Rochester, Minnesota 55905, United States; Recruiting
Zoran Kvrgic, CCRP, Phone: 507-538-3887, Email: kvrgic.zoran@mayo.edu
Eric L Matteson, M.D., Principal Investigator
Additional Information

Related publications:

Bingham CO 3rd, Pohl C, Woodworth TG, Hewlett SE, May JE, Rahman MU, Witter JP, Furst DE, Strand CV, Boers M, Alten RE. Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group). J Rheumatol. 2009 Oct;36(10):2335-41. doi: 10.3899/jrheum.090369. Epub 2009 Aug 14.

Starting date: March 2015
Last updated: July 24, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017